ARCHIVES

Two Avastin Trials Show OS Benefit In Advanced Disease

This article is from The Cancer Letter archive.

Vol. 33 No. 8 | August 27, 2010

Download PDF Visit The Full Archive

Related Articles

Clinical Oncology Program Has Top Priority Fink Says

February 9, 1979

Vaccine Increases PFS 146%, OS 60% In Phase II Clinical Trial

May 31, 2013

In Brief: Parkinson To Leave CTEP For Novartis; FTC To Permit Sandoz, Ciba-Geigy Merger

January 10, 1997

In Brief: Nabel To Direct Vaccine Research Center; Former NIH Director Robert Marston Is Dead

March 19, 1999

Dipersio Is Chief Of Oncology At Washington University.

July 14, 2000

Three researchers share Paul Marks Prize.

November 11, 2005